Related Experiment Video
Updated: Oct 4, 2025

Intratracheal Instillation of Stem Cells in Term Neonatal Rats
Published on: May 4, 2020
Respiratory distress syndrome in preterm infants: possible impact of surfactant application techniques
Pawel Krajewski1, Tomasz Pomianek2, Krzysztof Truszkowski1
1Medical University of Warsaw, Poland.
Insights
Minimally invasive surfactant administration (MISA) methods, including LISA and InSure, significantly reduced severe respiratory distress syndrome (RDS) in premature infants compared to traditional endotracheal tube methods. These less invasive techniques are safe and effective for treating RDS.
Area of Science:
- Neonatalogy
- Perinatology
- Pediatric Pulmonology
Background:
- Respiratory distress syndrome (RDS) is a primary cause of mortality and morbidity in premature infants due to lung immaturity and surfactant deficiency.
- Effective management of RDS is crucial for improving short- and long-term outcomes in very premature newborns.
Purpose of the Study:
- To compare the effectiveness of different surfactant administration techniques in treating respiratory disorders in premature infants.
- To evaluate the impact of traditional endotracheal tube surfactant delivery versus minimally invasive surfactant administration (MISA) methods.
Main Methods:
- A retrospective study of 198 very premature infants who received surfactant between 2009 and 2013.
- Infants were categorized into three groups based on surfactant application: traditional endotracheal tube, InSure method, and Less Invasive Surfactant Administration (LISA).
- Comparison of clinical data including gestational age, birth weight, and Apgar scores across the groups.
Main Results:
- Noninvasive respiratory support and MISA methods, such as LISA and InSure, demonstrated a significant reduction in the incidence of severe RDS compared to the traditional endotracheal tube method.
- Infants receiving surfactant via LISA and InSure methods generally had higher gestational ages, birth weights, and Apgar scores.
Conclusions:
- Minimally invasive surfactant administration (MISA) techniques, including LISA and InSure, are safe and effective in managing respiratory distress syndrome in premature infants.
- These advanced methods offer a significant improvement over traditional surfactant delivery through endotracheal tubes, reducing RDS severity.
Objectives:
Prematurity is one of the most important issues in perinatology. The most frequent postnatal pathology connected with prematurity is respiratory distress syndrome (RDS) caused by surfactant deficiency due to lung immaturity. RDS is one of the most frequent causes of mortality and morbidity with short- and long-term consequences. The aim of the study was to compare the effectiveness of individual surfactant supply techniques in the treatment of respiratory disorders in premature infants.
Material And Methods:
In the period from the year 2009 to 2013, there were 198 very premature infants that received surfactant included to this retrospective study. They were divided into three groups based on the surfactant application method: Premature newborns with substitute ventilation, with supply of surfactant through a traditional endotracheal tube - Average gestational age 26.6 weeks; Mean birth weight 911 g; Average Apgar score 4 in 1st minute, 6 in 5th minute. Premature newborns with exogenous surfactant supplementation - InSure method - Average gestational age 28.3 weeks; Average birth weight 1117 g; Mean Apgar score 6 in 1st minute, 7 in 5th minute. Premature newborns with exogenous surfactant supplementation - Less Invasive Surfactant Administration (LISA) method - Mean gestational age 29.9 weeks; Average birth weight 1444 g; Average Apgar score 7 in 1st minute, 8 in 5th minute.
Results:
Noninvasive methods of respiratory support and minimally invasive surfactant administration (MISA) significantly reduced the incidence of severe RDS, compared to the traditional method.
Conclusions:
Non-invasive methods of respiratory support and MISA like LISA and InSure methods were safe and effective in the treatment of RDS.
More Related Videos
06:22Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS
Published on: April 7, 2021
06:15Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
Related Concept Videos
Breathing
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Pulmonary Cycle: Exhalation
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Factors Affecting Pulmonary Ventilation
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
Cardiopulmonary Resuscitation V: Advanced Airway Management Techniques